http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2187289-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2cf1e2afe013e095a1e4322f7c0747e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate | 2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f125e99f591c1a45fe995ab8f4748b0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde7a409c8c5068af63e0b82535cb3fd |
publicationDate | 2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2187289-C1 |
titleOfInvention | Method for removing vast lower palpebral defects |
abstract | FIELD: medicine. SUBSTANCE: epidermal layer is removed from lateral part of a fragment, then its medial part is replaced into defect area through a preformed subcutaneous-muscular tunnel and the edge of lower palpebra is formed, conjunctiva is separated and fixed to external plate of sutured fragment. Moreover, an arch-shaped cutaneousmuscular fragment is cut in upper palpebral area. Additionally, palpebral edge is formed by turning in and suturing the upper edge of a fragment with linear stitches or mattress sutures. Before conjunctival separation it is baloonized with physiological solution. EFFECT: higher efficiency of operation. 3 cl |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2535455-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2729447-C1 |
priorityDate | 2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727 |
Total number of triples: 16.